326 related articles for article (PubMed ID: 12456792)
1. Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate.
Tamrazi A; Carlson KE; Daniels JR; Hurth KM; Katzenellenbogen JA
Mol Endocrinol; 2002 Dec; 16(12):2706-19. PubMed ID: 12456792
[TBL] [Abstract][Full Text] [Related]
2. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
[TBL] [Abstract][Full Text] [Related]
4. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
[TBL] [Abstract][Full Text] [Related]
5. Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.
Tamrazi A; Carlson KE; Rodriguez AL; Katzenellenbogen JA
Mol Endocrinol; 2005 Jun; 19(6):1516-28. PubMed ID: 15661830
[TBL] [Abstract][Full Text] [Related]
6. The human estrogen receptor alpha dimer binds a single SRC-1 coactivator molecule with an affinity dictated by agonist structure.
Margeat E; Poujol N; Boulahtouf A; Chen Y; Müller JD; Gratton E; Cavailles V; Royer CA
J Mol Biol; 2001 Feb; 306(3):433-42. PubMed ID: 11178903
[TBL] [Abstract][Full Text] [Related]
7. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.
Bramlett KS; Wu Y; Burris TP
Mol Endocrinol; 2001 Jun; 15(6):909-22. PubMed ID: 11376110
[TBL] [Abstract][Full Text] [Related]
8. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.
Hall JM; McDonnell DP; Korach KS
Mol Endocrinol; 2002 Mar; 16(3):469-86. PubMed ID: 11875105
[TBL] [Abstract][Full Text] [Related]
9. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
[TBL] [Abstract][Full Text] [Related]
10. Molecular sensors of estrogen receptor conformations and dynamics.
Tamrazi A; Carlson KE; Katzenellenbogen JA
Mol Endocrinol; 2003 Dec; 17(12):2593-602. PubMed ID: 12947047
[TBL] [Abstract][Full Text] [Related]
11. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Bai Y; Giguére V
Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
[TBL] [Abstract][Full Text] [Related]
12. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.
Chen D; Pace PE; Coombes RC; Ali S
Mol Cell Biol; 1999 Feb; 19(2):1002-15. PubMed ID: 9891036
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor microarrays: subtype-selective ligand binding.
Kim SH; Tamrazi A; Carlson KE; Daniels JR; Lee IY; Katzenellenbogen JA
J Am Chem Soc; 2004 Apr; 126(15):4754-5. PubMed ID: 15080660
[TBL] [Abstract][Full Text] [Related]
15. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.
Arao Y; Hamilton KJ; Coons LA; Korach KS
J Biol Chem; 2013 Jul; 288(29):21105-21116. PubMed ID: 23733188
[TBL] [Abstract][Full Text] [Related]
17. The nuclear receptor coactivator PGC-1alpha exhibits modes of interaction with the estrogen receptor distinct from those of SRC-1.
Bourdoncle A; Labesse G; Margueron R; Castet A; Cavaillès V; Royer CA
J Mol Biol; 2005 Apr; 347(5):921-34. PubMed ID: 15784253
[TBL] [Abstract][Full Text] [Related]
18. Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands.
Wong CW; Komm B; Cheskis BJ
Biochemistry; 2001 Jun; 40(23):6756-65. PubMed ID: 11389589
[TBL] [Abstract][Full Text] [Related]
19. A genetically encoded fluorescent indicator capable of discriminating estrogen agonists from antagonists in living cells.
Awais M; Sato M; Sasaki K; Umezawa Y
Anal Chem; 2004 Apr; 76(8):2181-6. PubMed ID: 15080726
[TBL] [Abstract][Full Text] [Related]
20. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
